Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -3972.87% is 152% below its 5-year average of -1576.62%, near the high end of its 5-year range (-21966.77%–2107.43%).
1089.87% below its 12-month average of -333.89%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): -1715.01%.
NET PROFIT MARGIN
-3972.87%
NET PROFIT MARGIN AVG TTM
-333.89%
NET PROFIT MARGIN AVG 3Y
-1392.26%
NET PROFIT MARGIN AVG 5Y
-1576.62%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1089.87%
CURRENT VS 3Y AVG
-185.35%
CURRENT VS 5Y AVG
-151.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-1135005.71%
vs the sector median at left
Optimi Health Corp.
Market Cap
$13.30M
Net Profit Margin
-3972.87%
TTM Avg
-333.89%
3Y Avg
-1392.26%
5Y Avg
-1576.62%
Market Cap
$13.20M
Net Profit Margin
-651.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.11M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.75M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.78M
Net Profit Margin
-2006.87%
TTM Avg
-2784.80%
3Y Avg
-10458.57%
5Y Avg
-6972.38%
Market Cap
$13.86M
Net Profit Margin
-1303.40%
TTM Avg
-1281.42%
3Y Avg
-1220.10%
5Y Avg
-1266.64%
Market Cap
$12.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$14.05M
Net Profit Margin
-39.61%
TTM Avg
-209.93%
3Y Avg
-392.71%
5Y Avg
-532.46%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.30M | -3972.87% | -333.89% | -1392.26% | -1576.62% |
| IN8bio, Inc. (INAB)vs › | $13.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -651.27% | 0.00% | 0.00% | 0.00% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | -2006.87% | -2784.80% | -10458.57% | -6972.38% |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -1303.40% | -1281.42% | -1220.10% | -1266.64% |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | -39.61% | -209.93% | -392.71% | -532.46% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | -804.37% | -21365.78% | -11028.80% | -7352.54% |
Operating Margin
-1062.3%
Net Profit Margin
-3972.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1715.01% |
| 2026-03-31 | -1599.87% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 2107.43% |
| 2025-06-30 | -462.00% |
| 2025-03-31 | -320.64% |
| 2024-12-31 | -541.03% |
| 2024-09-30 | -2978.25% |
| 2024-06-30 | -1311.62% |
| 2024-03-31 | -1741.52% |
| 2023-12-31 | -1182.38% |
| 2023-09-30 | -6644.77% |
| 2023-06-30 | -3462.52% |
| 2023-03-31 | -1732.99% |
| 2022-12-31 | -2513.64% |
| 2022-09-30 | -3908.44% |
| 2022-06-30 | -3525.19% |
| 2022-03-31 | -21966.77% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 0.00% |
